AbbVie Names Robert A. Michael CEO; Richard A. Gonzalez To Become Executive Chairman
AbbVie Names Robert A. Michael CEO; Richard A. Gonzalez To Become Executive Chairman
艾伯维公司任命Robert A. Michael为CEO；Richard A. Gonzalez将成为执行董事长。
- As Previously Announced, Richard A. Gonzalez Retires as Chief Executive Officer to Become Executive Chairman
- Robert A. Michael Joins AbbVie Board of Directors
- 如之前所述，理查德·冈萨雷斯卸任首席执行官，担任执行董事长。
- 罗伯特·A·迈克尔加入艾伯维公司董事会。
NORTH CHICAGO, Ill., July 1, 2024 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that Robert A. Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors, effective today. As previously announced, Mr. Michael succeeds Richard A. Gonzalez, who has served as CEO since the company's inception in 2013. Mr. Gonzalez has become executive chairman of the board of directors.
2024年7月1日，伊利诺伊州北芝加哥/美通社--艾伯维公司（纽交所:ABBV）今日宣布，罗伯特·迈克尔（Robert A. Michael）已经就任首席执行官（CEO），并于今日加入艾伯维公司的董事会。如此前宣布，迈克尔先生接替自2013年公司成立以来一直担任CEO的理查德·冈萨雷斯（Richard A. Gonzalez）。冈萨雷斯先生已成为董事会的执行主席。